The Proliferative Cell Fraction in Cytology Specimens: A Study of Human Esophageal Carcinoma

1992 ◽  
Vol 98 (2) ◽  
pp. 161-166 ◽  
Author(s):  
Hironobu Sasano ◽  
Shukichi Miyazaki ◽  
Tetsurou Nishihira ◽  
Takashi Sawai ◽  
Hiroshi Nagura
Keyword(s):  
Esophageal Carcinoma ◽  
Cell Fraction ◽  
Proliferative Cell

Application of the Monoclonal Antibody Ki-67 on Prostate Biopsies to Assess the Proliferative Cell Fraction of Human Prostatic Carcinoma

1991 ◽  
Vol 145 (1) ◽  
pp. 81-85 ◽  
Author(s):  
E.H.G.M. Oomens ◽  
G.J. Van Steenbrugge ◽  
Th.H. Van Der Kwast ◽  
F.H. Schröder
Keyword(s):  
Monoclonal Antibody ◽  
Prostatic Carcinoma ◽  
Cell Fraction ◽  
Ki 67 ◽  
Prostate Biopsies ◽  
Proliferative Cell

Reduced expression of TMEM166 is associated with esophageal carcinoma and gastric cancer

2010 ◽  
Vol 34 (8) ◽  
pp. S54-S54
Author(s):  
Dong Xu ◽  
Ying Chang ◽  
Huiying He ◽  
Yingyu Chen
Keyword(s):  
Gastric Cancer ◽  
Esophageal Carcinoma

Genomic alterations of micrometastatic tumor cells in patients with operable esophageal carcinoma

2001 ◽  
Vol 120 (5) ◽  
pp. A344-A344
Author(s):  
N STOECKLEIN ◽  
M PETRONIO ◽  
T BLANKENSTEIN ◽  
S HOSCH ◽  
A ERBERSDOBLER ◽  
...  
Keyword(s):  
Esophageal Carcinoma ◽  
Tumor Cells ◽  
Genomic Alterations

Immunohistochemical (IH) detection of lymph node (LN) micrometastases (MM) dies not predict survival of patient (PT) with node negative esophageal carcinoma (EC)

2001 ◽  
Vol 120 (5) ◽  
pp. A443-A443
Author(s):  
E VAZQUEZSEQUEIROS ◽  
L WANG ◽  
L BURGART ◽  
W HARMSEN ◽  
A ZINSMEISTER ◽  
...  
Keyword(s):  
Lymph Node ◽  
Esophageal Carcinoma ◽  
Node Negative

Treatment of Malignant Esophageal Fistulas: Fluoroscopic Placement of Esophageal SEMS, Endoscopically-assisted through Surgical Gastrostomy. A Case Report

2016 ◽  
Vol 25 (2) ◽  
pp. 249-252 ◽  
Author(s):  
Gabriel Constantinescu ◽  
Vasile Şandru ◽  
Mădălina Ilie ◽  
Cristian Nedelcu ◽  
Radu Tincu ◽  
...  
Keyword(s):  
Esophageal Carcinoma ◽  
Guide Wire ◽  
Subsequent Development ◽  
Covered Stent ◽  
Metallic Stents ◽  
Fistula Formation ◽  
Life Threatening ◽  
Endoscopic Placement ◽  
Surgical Gastrostomy ◽  
Methods Of Treatment

Progressive esophageal carcinoma can infiltrate the surrounding tissues with subsequent development of a fistula, most commonly between the esophagus and the respiratory tract. The endoscopic placement of covered self-expanding metallic stents (SEMS) is the treatment of choice for malignant esophageal fistulas and should be performed immediately, as a fistula formation represents a potential life-threatening complication. We report the case of a 64-year-old male diagnosed with esophageal carcinoma, who had a 20Fr surgical gastrostomy tube inserted before chemo- and radiotherapy and was referred to our department for complete dysphagia, cough after swallowing and fever. The attempt to insert a SEMS using the classic endoscopic procedure failed. Then, a fully covered stent was inserted, as the 0.035” guide wire was passed through stenosis retrogradely by using an Olympus Exera II GIF-N180 (4.9 mm in diameter endoscope) via surgical gastrostomy, with a good outcome for the patient. The retrograde approach via gastrostomy under endoscopic/fluoroscopic guidance with the placement of a fully covered SEMS proved to be the technique of choice, in a patient with malignant esophageal fistula in whom other methods of treatment were not feasible. Abbreviations: ERCP: endoscopic retrograde cholangio-pancreatography; GI: gastrointestinal; SEMS: self-expandable metallic stents.

Total FDG lesion number on PET/CT predicts survival of esophageal carcinoma patients with recurrence following curative surgery

2020 ◽  
Vol 64 (2) ◽  
Author(s):  
Soo J. Kim ◽  
Seung H. Hyun ◽  
Seung H. Moon ◽  
Young S. Cho ◽  
Hyun K. Yi ◽  
...  
Keyword(s):  
Esophageal Carcinoma ◽  
Curative Surgery ◽  
Pet Ct ◽  
Lesion Number
Sign in / Sign up

Export Citation Format

Share Document